{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:36Z","timestamp":1794047496222,"version":"4.8.0"},"reference-count":15,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"10","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2024.287047","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T03:08:34Z","timestamp":1744859314000},"page":"2487-2492","source":"Crossref","is-referenced-by-count":4,"title":["Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma"],"prefix":"10.3324","volume":"110","author":[{"given":"Ingrid","family":"Quist-Lokken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Tilseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Andersson-Rusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Abu","family":"Hanif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Walz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna Fredrikke Nordstrand","family":"Moen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan Anne","family":"Vik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias Schmidt","family":"Slordahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Sundan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Hausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toril","family":"Holien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"80578","doi-asserted-by":"crossref","unstructured":"Rajkumar SV. Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol. 2024; 99(9):1802-1824.","DOI":"10.1002\/ajh.27422"},{"key":"80579","doi-asserted-by":"crossref","unstructured":"Martinez-Hackert E, Sundan A, Holien T. Receptor binding competition: a paradigm for regulating TGF-\u03b2 family action. Cytokine Growth Factor Rev. 2021; 57:39-54.","DOI":"10.1016\/j.cytogfr.2020.09.003"},{"key":"80580","doi-asserted-by":"crossref","unstructured":"Massagu\u00e9 J, Seoane J, Wotton D. Smad transcription factors. Genes Dev. 2005; 19(23):2783-2810.","DOI":"10.1101\/gad.1350705"},{"key":"80581","doi-asserted-by":"crossref","unstructured":"Wang T, Li BY, Danielson PD. The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors. Cell. 1996; 86(3):435-444.","DOI":"10.1016\/S0092-8674(00)80116-6"},{"key":"80582","doi-asserted-by":"crossref","unstructured":"Holien T, V\u00e5tsveen TK, Hella H. Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC. Leukemia. 2012; 26(5):1073-1080.","DOI":"10.1038\/leu.2011.263"},{"key":"80583","doi-asserted-by":"crossref","unstructured":"Holien T, V\u00e5tsveen TK, Hella H, Waage A, Sundan A. Addiction to c-MYC in multiple myeloma. Blood. 2012; 120(12):2450-2453.","DOI":"10.1182\/blood-2011-08-371567"},{"key":"80584","doi-asserted-by":"crossref","unstructured":"Quist-L\u00f8kken I, Andersson-Rusch C, Kastnes MH. FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells. Cell Commun Signal. 2023; 21(1):25.","DOI":"10.1186\/s12964-022-01033-9"},{"key":"80585","doi-asserted-by":"crossref","unstructured":"Crabtree GR, Olson EN. NFAT signaling: choreographing the social lives of cells. Cell. 2002; 109(Suppl):S67-79.","DOI":"10.1016\/S0092-8674(02)00699-2"},{"key":"80586","doi-asserted-by":"crossref","unstructured":"Zhong T, Sun X, Yu L. PROTAC mediated FKBP12 degradation enhances hepcidin expression via BMP signaling without immunosuppression activity. Signal Transduct Target Ther. 2022; 7(1):163.","DOI":"10.1038\/s41392-022-00970-8"},{"key":"80587","doi-asserted-by":"crossref","unstructured":"B\u00e9k\u00e9s M, Langley DR, Crews CM. PROTAC targeted protein degraders: the past is prologue. Nat Rev Drug Discov. 2022; 21(3):181-200.","DOI":"10.1038\/s41573-021-00371-6"},{"key":"80588","doi-asserted-by":"crossref","unstructured":"Geiger TM, Walz M, Meyners C. Discovery of a potent proteolysis targeting chimera enables targeting the scaffolding functions of FK506-binding protein 51 (FKBP51). Angew Chem Int Ed Engl. 2024; 63(3):e202309706.","DOI":"10.1002\/anie.202309706"},{"key":"80589","doi-asserted-by":"crossref","unstructured":"Sun X, Wang J, Yao X. A chemical approach for global protein knockdown from mice to non-human primates. Cell Discov. 2019; 5:10.","DOI":"10.1038\/s41421-018-0079-1"},{"key":"80590","doi-asserted-by":"crossref","unstructured":"Purder PL, Meyners C, Sugiarto WO. Deconstructing protein binding of sulfonamides and sulfonamide analogues. JACS Au. 2023; 3(9):2478-2486.","DOI":"10.1021\/jacsau.3c00241"},{"key":"80591","doi-asserted-by":"crossref","unstructured":"Kolos JM, Pomplun S, Jung S. Picomolar FKBP inhibitors enabled by a single water-displacing methyl group in bicyclic [4.3.1] aza-amides. Chem Sci. 2021; 12(44):14758-14765.","DOI":"10.1039\/D1SC04638A"},{"key":"80592","doi-asserted-by":"crossref","unstructured":"Lu G, Middleton RE, Sun H. The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins. Science. 2014; 343(6168):305-309.","DOI":"10.1126\/science.1244917"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/12027\/78290","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/12027\/78887","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/12027\/78290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:08:36Z","timestamp":1794046116000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/12027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":15,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2024.287047","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,17]]}}}